ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OSTX vs RNXT // RSI-14 & 200D SMA MOMENTUM

OS Therapies Incorporated (NYSE) VS. RenovoRx Inc. (NASDAQ) • 15-METRIC TALLY: OSTX 1 — RNXT 3
▲ RSI-14 & 200D SMA MOMENTUM LEADER: RNXT
rsi-technicals
47.1
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OSTX VS. RNXT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OSTX RNXT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 70.90% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -21.07% -16.32% -4.75 RNXT /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 180.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.40 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 4/9 -3.00 RNXT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 33.8 47.1 -13.28 RNXT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $67.6M $67.2M $341.5K OSTX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OSTX REV RNXT REV OSTX GROSS % RNXT GROSS % OSTX FCF RNXT FCF
FY 2025 $0 $1.1M — 70.9% -$14.2M -$11.0M
FY 2024 $0 $43.0K — 98.0% -$7.3M -$9.1M
FY 2023 $0 $0 — — -$3.0M -$10.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OSTX // BETA —
RNXT // BETA —